CoreAge Rx Review

• Flat pricing by dose, stated in CoreAge's own FAQ: the price locked in at checkout “stays the same for all future months, regardless of dose increases”
• Prescribing entities named in full, which most programmes we list do not do
• Semaglutide $99 a month, tirzepatide $149, with dose-capped alternatives at $79 and $129 (checked 23 September 2026)
• Free shipping, and no separate membership fee
• A provider consultation fee of $50 to $100 that the refund policy states is non-refundable
• No named pharmacy and no published list of states served

Compounded semaglutide and compounded tirzepatide as weekly injections, lower-dose microdosing versions of both, NAD+ as an injection and as a nasal spray, and sermorelin. CoreAge also sells skincare, an ED product and supplements that sit outside the prescription lines. Treatment is prescribed only where a clinician from one of its named prescribing entities judges it appropriate.

An online qualification form, reviewed by a licensed provider. CoreAge states it charges you before that review happens: its FAQ says payment “locks in your pricing and places you in the pharmacy queue”. The consultation fee is $50 to $100 depending on treatment and is not refunded once the review has begun.

Free standard shipping on prescription orders, stated as arriving in about 2 to 3 business days after the pharmacy ships. CoreAge puts the typical end-to-end time at about 5 to 7 business days, because medical review, documentation and compounding happen first.

Checked 23 September 2026 on CoreAge's own pages. Semaglutide is $99 a month and tirzepatide is $149. NAD+ is $93 in either form, sermorelin is $99, and the microdosing versions are $149 for semaglutide and $199 for tirzepatide.

That last pair is worth pausing on, because it runs the other way from every other programme we list: at CoreAge the lower-dose option costs MORE than the standard one, not less. If you are choosing microdosing to spend less, that is not what it does here.

The bigger source of confusion is that a separate partner landing page advertises semaglutide at $79 and tirzepatide at $129. Those are not discounts on the $99 and $149 plans. They are dose-capped products, and CoreAge says so in its own words: “any dose up to 1.0 mg” for the $79 semaglutide plan and “any dose up to 7.5 mg” for the $129 tirzepatide plan. If your clinician takes you above the cap, that plan no longer covers you.

One limitation on everything above. CoreAge's checkout tiers sit behind a medical qualification form, so we could not price a basket without submitting health information, which we did not do. Every figure here comes from public marketing pages.

CoreAge's product pages carry the lines “UPFRONT PRICING, NO HIDDEN FEES” and “NO MEMBERSHIP FEES”, and its partner landing page says “No Membership Fee. No Hidden Fees. Everything Included”. Its refund policy says something else: “Any applicable provider consultation fee of $50 to $100 is non-refundable, because the medical consultation and eligibility review have already been performed.”

Strictly, both can be true at once. A consultation fee is not a membership fee. But “everything included” is doing work the pricing does not support, and a reader who took the marketing at face value would not expect to pay $50 to $100 on top of the monthly figure.

Now read it next to two other terms. CoreAge charges you before a clinician reviews your case, and says why: payment “locks in your pricing and places you in the pharmacy queue”. And the refund policy states that the consultation fee “may remain non-refundable even if you cancel before pharmacy fulfilment”.

Put together, those mean a reader can pay, be found medically ineligible, and still be out $50 to $100. The medication portion is returned in that case. The fee for the review that turned them down is not. That is the single most important thing to understand before starting an order with CoreAge, and it is the reason this section exists.

Separately, once a prescription has been approved and transmitted to the pharmacy, CoreAge states that all prescription sales are final. That applies even before the medication ships and even if you change your mind.

CoreAge's partner landing page badges its two dose-capped plans as “68% OFF” on tirzepatide and “58% OFF” on semaglutide. We are reporting those badges rather than passing them on as savings, because there is nothing published to check them against.

CoreAge publishes no list price. Not on the landing page, not on its product pages, not anywhere we read on 23 September 2026. There is no struck-through figure beside either badge.

The one other number on that page is $300, and it is not CoreAge's own former price. It appears in copy about other providers: “with many other programs, that means your monthly bill goes up after the first month. Your bill doubles. Sometimes triples. Suddenly, you are paying $300+ per month.” That is competitor framing, not a compare-at.

The arithmetic does not work either way. If $300 were the reference, $129 would be 57% off and $79 would be 73.7% off, not the 68% and 58% on the badges. For the badges to be accurate the reference prices would have to be about $403 and $188, and neither figure appears anywhere on the site. A percentage off nothing is not a saving you can verify, so treat the monthly figure as the price and ignore the badge.

This is where CoreAge does better than most. Its terms name the operating company as DSO Fine Shrimp LLC, trading as CoreAge Rx, and name all three prescribing entities: M & D Integrations Inc trading as MD Integrations, MDI Medical Group P.C., and MD Integrations & Wellness Provider Group P.A. It states that these are independently owned and operated, and that CoreAge itself “does not provide medical services, does not employ healthcare providers, does not participate in clinical decisions, and does not practice medicine”. Several programmes we list name no prescribing entity at all.

The pharmacy is a gap. CoreAge says a prescription is “transmitted to a licensed pharmacy for compounding and fulfillment” and never names it. No individual clinician is named either.

The published address is 1309 Coffeen Avenue, Suite 1200, Sheridan, Wyoming 82801. That address is not an office. It belongs to Wyoming LLC Attorney, formerly Cloud Peak Law Group, a firm that provides company formation and registered agent services, and public business records list roughly 25 companies registered at it, several sharing the same suite number. Using a registered agent is ordinary and lawful for a Wyoming company, and it implies nothing improper. It does mean the published address tells you nothing about where CoreAge operates from, and CoreAge publishes no operating address that does.

States served are a gap too. CoreAge says it serves “multiple states” and that a provider must hold a licence in yours. It publishes no list, so the only way to find out is to begin intake.

On 23 September 2026 CoreAge was running different promotional framings depending on how you arrived. Its partner landing page carried a “SUMMER SALE” badge. Its own application funnel carried “FALL SALE Save $350+ Automatically” above a countdown timer reading just under three hours.

We are reporting that as observed on the date rather than drawing a conclusion from it. Two things are worth a reader knowing. A summer sale still badged in late September is a label rather than a season. And a three-hour countdown on a page anyone can reload is a design pattern, not a deadline: if the offer is still there tomorrow, the timer was not counting down to anything.

None of this bears on whether the treatment is appropriate for you, and neither figure changes the monthly prices recorded above.

PCF reviews online programs for comparison purposes only. Provider details, pricing, availability, and medication paths can change. Confirm current terms directly and consult a licensed clinician before making medical decisions.